Use of Mefenamic Acid as a Supportive Treatment of COVID-19: A Repurposing Drug
Journal: International Journal of Science and Research (IJSR) (Vol.9, No. 6)Publication Date: 2020-06-05
Authors : R. P. Pareek;
Page : 69-73
Keywords : COVID-19; SARS-CoV-2; Mefenamic acid; serine protease inhibitor; NLRP3 inflammasome;
Abstract
COVID-19 (coronavirus disease 2019) is a Pandemic of concern, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As of now, there is no known effective pharmaceutical or other medicine available for cure or prevention of COVID-19. In this review, based on the current understanding of the disease and the structure of novel Coronavirus SARS-CoV-2, SARS-CoV and other human viruses, I have identified Mefenamic Acid, an anti-inflammatory medicine, of having some role as an anti-viral medicine also. It can be used along with different anti-viral drugs being tried for the treatment of Covid 19. Since it is also an anti-pyretic, its main role may be of bringing down the fever but its action as an anti-viral, as a supportive medicine can very useful. Clincal trials with this concept in mind can be started immediately at the Centre dedicated for treatment of Covid 19.
Other Latest Articles
- Kuka-Krunic Hypothesis about Pre-Determination of Psychophysical Capacities of an Individual with Inability to Influence their Change
- Flood Study in Balrampur District of Uttar Pradesh India
- Local Wisdom of Kendeng Indigenous Law Communities in Maintain Environmental Balance in the Middle of COVID-19 Pandemic
- Lumbar Segmental Motion: A Correlation of Clinical Symptoms with MRI and Dynamic Radiograph
- Effect of Client Appraisal on Financial Performance of Financial Institutions in Rwanda: A Case Study of Guaranty Trust Bank Rwanda PLC
Last modified: 2021-06-28 17:08:00